DNA X, Inc. Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price
DNA X, Inc. (SONM) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price of $103.68 per share for the 12-month period ending 2024-12-31, per its 10-K filed 2026-04-15.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice · last filed 2026-04-15
- DNA X, Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2024-03-31 was $0.72, a 44.00% increase year-over-year.
- DNA X, Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2023-03-31 was $0.50.
- DNA X, Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2024 was $103.68, a 1706.27% increase from fiscal 2023.
- DNA X, Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2023 was $5.74, a 1204.55% increase from fiscal 2022.
- DNA X, Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2022 was $0.44.
- DNA X, Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2020 was $8.58, a 44.44% increase from fiscal 2019.
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 3 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 9 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 12 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 12 month as first filed |
|---|---|---|---|---|---|
| 2024-12-31 | $103.68 10-K · filed 2026-04-15 | $5.76 10-K · filed 2025-03-31 | |||
| 2024-09-30 | $5.92 10-Q · filed 2024-11-13 | ||||
| 2024-06-30 | $6.16 10-Q · filed 2024-08-09 | ||||
| 2024-03-31 | $0.72 10-Q · filed 2024-05-14 | ||||
| 2023-12-31 | $5.74 10-K · filed 2025-03-31 | $0.57 10-K · filed 2024-03-27 | |||
| 2023-09-30 | $0.54 10-Q · filed 2023-11-14 | ||||
| 2023-06-30 | $0.54 10-Q · filed 2023-08-14 | ||||
| 2023-03-31 | $0.50 10-Q · filed 2023-05-08 | ||||
| 2022-12-31 | $0.44 10-K · filed 2024-03-27 | ||||
| 2020-12-31 | $8.58 10-K/A · filed 2022-06-29 | $0.86 10-K · filed 2021-03-18 | |||
| 2020-09-30 | $0.86 10-Q · filed 2020-11-12 | ||||
| 2020-06-30 | $0.85 10-Q · filed 2020-08-12 | ||||
| 2019-12-31 | $5.94 10-K · filed 2021-03-18 | ||||
| 2019-09-30 | $10.94 10-Q · filed 2019-11-12 | ||||
| 2019-06-30 | $10.94 10-Q · filed 2019-08-13 | ||||
| 2018-12-31 | $0.90 10-K · filed 2020-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CLEARONE INC (CLRO) | United States | $0.009B | |
| FRANKLIN WIRELESS CORP (FKWL) | United States | $0.028B | -61.80 |
| FiEE, Inc. (FIEE) | Japan | $0.033B | 8.06 |
| Clearfield, Inc. (CLFD) | United States | $0.415B | -74.88 |
| ADTRAN Holdings, Inc. (ADTN) | United States | $0.565B | -43.25 |
| Fabrinet (FN) | $14.287B | 39.79 | |
| CIENA CORP (CIEN) | United States | $50.874B | 81.72 |